FdaApplication
ANDA 076021
Identifiers
- fda_app_no: ANDA076021
Properties
| Property | Value |
|---|---|
| applicant_name | RANBAXY LABORATORIES LTD |
| application_type | ANDA |
| approval_date | 2002-08-22 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TERAZOSIN HYDROCHLORIDE | TERAZOSIN HYDROCHLORIDE | EQ 1MG BASE | CAPSULE;ORAL |
| TERAZOSIN HYDROCHLORIDE | TERAZOSIN HYDROCHLORIDE | EQ 10MG BASE | CAPSULE;ORAL |
| TERAZOSIN HYDROCHLORIDE | TERAZOSIN HYDROCHLORIDE | EQ 5MG BASE | CAPSULE;ORAL |
| TERAZOSIN HYDROCHLORIDE | TERAZOSIN HYDROCHLORIDE | EQ 2MG BASE | CAPSULE;ORAL |
4 products